Wang, Xiang
Sichuan University · West China Second University Hospital of Sichuan University
3 papers on CoChatORCID 0000-0002-0913-0501
Most cited papers
- Verified
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Richardson, P. G., Oriol, A., Beksac, M., Liberati, A. M., Galli, M., Schjesvold, F., Lindsay, J., Weisel, K., White, D., Facon, T., et al. (2019) · The Lancet Oncology
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 386
- Verified
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer
Yu, K.-D., Zhou, Y., Liu, G.-Y., Li, B., He, P.-Q., Zhang, H.-W., Lou, L.-H., Wang, X.-J., Wang, S., Tang, J.-H., et al. (2012) · Breast Cancer Research and Treatment
Medication Adherence and ComplianceCancer survivorship and care
Cited by 50
- Verified
Sequencing of the ZMYND15 gene in a cohort of infertile Chinese men reveals novel mutations in patients with teratozoospermia
Wen, Y., Wang, X., Zheng, R., Dai, S., Li, J., Yang, Y., & Shen, Y. (2023) · Journal of Medical Genetics
Sperm and Testicular FunctionGenomics and Rare Diseases
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free